Loading...
Targeting bioenergetics is key to counteracting the drug-tolerant state of biofilm-grown bacteria.
Donnert, Monique Elsheikh, Sarah Arce-Rodriguez, Alejandro Pawar, Vinay Braubach, Peter Jonigk, Danny Haverich, Axel Weiss, Siegfried Müsken, Mathias Häussler, Susanne
Donnert, Monique
Elsheikh, Sarah
Arce-Rodriguez, Alejandro
Pawar, Vinay
Braubach, Peter
Jonigk, Danny
Haverich, Axel
Weiss, Siegfried
Müsken, Mathias
Häussler, Susanne
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-12-22
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 2.29 MB
Other Titles
Abstract
Embedded in an extracellular matrix, biofilm-residing bacteria are protected from diverse physicochemical insults. In accordance, in the human host the general recalcitrance of biofilm-grown bacteria hinders successful eradication of chronic, biofilm-associated infections. In this study, we demonstrate that upon addition of promethazine, an FDA approved drug, antibiotic tolerance of in vitro biofilm-grown bacteria can be abolished. We show that following the addition of promethazine, diverse antibiotics are capable of efficiently killing biofilm-residing cells at minimal inhibitory concentrations. Synergistic effects could also be observed in a murine in vivo model system. PMZ was shown to increase membrane potential and interfere with bacterial respiration. Of note, antibiotic killing activity was elevated when PMZ was added to cells grown under environmental conditions that induce low intracellular proton levels. Our results imply that biofilm-grown bacteria avoid antibiotic killing and become tolerant by counteracting intracellular alkalization through the adaptation of metabolic and transport functions. Abrogation of antibiotic tolerance by interfering with the cell's bioenergetics promises to pave the way for successful eradication of biofilm-associated infections. Repurposing promethazine as a biofilm-sensitizing drug has the potential to accelerate the introduction of new treatments for recalcitrant, biofilm-associated infections into the clinic.
Citation
PLoS Pathog. 2020 Dec 22;16(12):e1009126. doi: 10.1371/journal.ppat.1009126.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
1553-7374
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International